Additional Information
Book Details
Abstract
This issue of Sleep Medicine Clinics is edited by Dr. Rami Khayat and focuses on Sleep and the Heart. Article topics include: Mechanisms of SDB and respiratory control instability in heart failure; Rehabilitation of cardiovascular disorders and sleep apnea; Device therapy for SDB in patients with CVD and heart failure; Non-mask based therapies for CSA in patients with heart failure; Movement disorders and non- respiratory sleep disorders in patients with CVD; A practical approach to the identification and management of SDB in heart failure patients.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front Cover | Cover | ||
Sleep and the Heart | i | ||
Copyright\r | ii | ||
CME Accreditation Page | iii | ||
PROGRAM OBJECTIVE | iii | ||
TARGET AUDIENCE | iii | ||
LEARNING OBJECTIVES | iii | ||
ACCREDITATION | iii | ||
DISCLOSURE OF CONFLICTS OF INTEREST | iii | ||
UNAPPROVED/OFF-LABEL USE DISCLOSURE | iii | ||
TO ENROLL | iii | ||
METHOD OF PARTICIPATION | iii | ||
CME INQUIRIES/SPECIAL NEEDS | iv | ||
SLEEP MEDICINE CLINICS\r | v | ||
FORTHCOMING ISSUES | v | ||
September 2017 | v | ||
December 2017 | v | ||
March 2018 | v | ||
RECENT ISSUES | v | ||
March 2017 | v | ||
December 2016 | v | ||
September 2016 | v | ||
Contributors | vii | ||
CONSULTING EDITOR | vii | ||
EDITOR | vii | ||
AUTHORS | vii | ||
Contents | ix | ||
Preface: Sleep and the Heart: What’s Next? | ix | ||
Sleep Architecture and Blood Pressure | ix | ||
The Effects of Insomnia and Sleep Loss on Cardiovascular Disease | ix | ||
Sleep and the Cardiovascular System in Children | ix | ||
Rehabilitation of Cardiovascular Disorders and Sleep Apnea | ix | ||
A Practical Approach to the Identification and Management of Sleep-Disordered Breathing in Heart Failure Patients | x | ||
Central Sleep Apnea in Patients with Congestive Heart Failure | x | ||
Sleep-Disordered Breathing and Arrhythmia in Heart Failure Patients | x | ||
Device Therapy for Sleep-Disordered Breathing in Patients with Cardiovascular Diseases and Heart Failure | x | ||
Non–Mask-based Therapies for Central Sleep Apnea in Patients with Heart Failure | xi | ||
Preface:\rSleep and the Heart: What’s Next? | xiii | ||
REFERENCES | xiv | ||
Sleep Architecture and Blood Pressure | 161 | ||
Key points | 161 | ||
INTRODUCTION | 161 | ||
SLEEP AND CARDIOVASCULAR INTERACTION | 162 | ||
Changes in Circulatory Control | 162 | ||
Cardiovascular Response During Non-Rapid Eye Movement Sleep | 162 | ||
Cardiovascular Response During Rapid Eye Movement Sleep | 163 | ||
Arousals | 163 | ||
Cardiorespiratory Coupling During Sleep | 163 | ||
CLINICAL IMPLICATIONS | 164 | ||
SUMMARY | 164 | ||
REFERENCES | 164 | ||
The Effects of Insomnia and Sleep Loss on Cardiovascular Disease | 167 | ||
Key points | 167 | ||
INTRODUCTION | 167 | ||
SLEEP AND HEALTH | 167 | ||
SLEEP AND ITS EFFECTS ON IMMUNITY AND METABOLIC ACTIVITY | 168 | ||
SLEEP LOSS, INSOMNIA, AND DIABETES | 169 | ||
SLEEP AND HYPERTENSION | 171 | ||
SLEEP AND CARDIOVASCULAR DISEASE | 172 | ||
SUMMARY | 174 | ||
REFERENCES | 174 | ||
Sleep and the Cardiovascular System in Children | 179 | ||
Key points | 179 | ||
INTRODUCTION | 179 | ||
PHYSIOLOGY AND PATHOPHYSIOLOGY | 179 | ||
Cardiovascular Physiology of Sleep in Children | 179 | ||
Pathophysiology | 180 | ||
SLEEP-DISORDERED BREATHING AND CARDIOVASCULAR DISEASE IN CHILDREN | 180 | ||
Obstructive Sleep Apnea | 180 | ||
Central Sleep Apnea | 181 | ||
Pathophysiology | 181 | ||
Sudden Infant Death Syndrome | 182 | ||
Congenital Central Hypoventilation Syndrome | 182 | ||
SLEEP MANIFESTATIONS OF CARDIOVASCULAR DISEASE | 182 | ||
Congenital Heart Disease | 182 | ||
The effect of obesity in children with congenital heart disease | 183 | ||
Cardiomyopathy in Children | 184 | ||
Duchenne muscular dystrophy | 184 | ||
Cardiac remodeling in obstructive sleep apnea in children | 184 | ||
Pediatric Heart Transplant | 185 | ||
SLEEP AND CARDIOVASCULAR MORBIDITY IN SPECIFIC GENETIC SYNDROMES AND SYSTEMIC DISEASE IN CHILDREN | 185 | ||
Down Syndrome | 185 | ||
Achondroplasia | 185 | ||
Marfan Syndrome | 185 | ||
Mucopolysaccharidosis | 186 | ||
Glycogen Storage Disorder | 186 | ||
Pierre Robin Sequence | 186 | ||
Apert Syndrome, Crouzon Syndrome, and Pfeiffer Syndrome | 186 | ||
Sickle Cell Disease | 186 | ||
SUMMARY | 186 | ||
REFERENCES | 187 | ||
Rehabilitation of Cardiovascular Disorders and Sleep Apnea | 193 | ||
Key points | 193 | ||
INTRODUCTION | 193 | ||
PREVALENCE OF OBSTRUCTIVE SLEEP APNEA IN PATIENTS ENTERING CARDIAC REHABILITATION PROGRAMS | 194 | ||
PREVALENCE OF OBSTRUCTIVE SLEEP APNEA IN THE POSTSTROKE PERIOD | 194 | ||
WHY OBSTRUCTIVE SLEEP APNEA IS UNDER-RECOGNIZED IN STROKE AND CARDIAC REHABILITATION UNITS | 194 | ||
OBSTRUCTIVE SLEEP APNEA AND REHABILITATION OUTCOME | 195 | ||
EARLY TREATMENT OF OBSTRUCTIVE SLEEP APNEA IN STROKE REHABILITATION | 197 | ||
EARLY TREATMENT OF OBSTRUCTIVE SLEEP APNEA IN CARDIOVASCULAR REHABILITATION | 198 | ||
SUMMARY | 198 | ||
REFERENCES | 199 | ||
A Practical Approach to the Identification and Management of Sleep-Disordered Breathing in Heart Failure Patients | 205 | ||
Key points | 205 | ||
INTRODUCTION | 205 | ||
DEFINITION AND CLASSIFICATION OF SLEEP-DISORDERED BREATHING | 206 | ||
THE EPIDEMIOLOGY OF SLEEP-DISORDERED BREATHING IN HEART FAILURE | 206 | ||
PATHOPHYSIOLOGY OF SLEEP DISORDERED BREATHING | 207 | ||
Obstructive Sleep Apnea | 207 | ||
Central Sleep Apnea | 207 | ||
Recognition of Sleep-Disordered Breathing in Heart Failure | 208 | ||
Comprehensive heart sleep history | 208 | ||
Clinical examination in sleep-disordered breathing | 209 | ||
Sleep-disordered breathing testing | 209 | ||
Nocturnal polysomnography | 209 | ||
Ambulatory sleep testing | 209 | ||
TREATMENT OF SLEEP-DISORDERED BREATHING IN HEART FAILURE PATIENTS | 210 | ||
TREATMENT OF OBSTRUCTIVE SLEEP APNEA | 210 | ||
TREATMENT OF CENTRAL SLEEP APNEA | 213 | ||
SUMMARY | 214 | ||
REFERENCES | 215 | ||
Central Sleep Apnea in Patients with Congestive Heart Failure | 221 | ||
Key points | 221 | ||
DETERMINANTS OF BREATHING INSTABILITY DURING NON–RAPID EYE MOVEMENT SLEEP | 221 | ||
Determinants of Central Apnea During Sleep | 221 | ||
Determinants of Periodic Breathing During Sleep | 222 | ||
Role of Central Apnea in the Development of Obstructive Sleep Apnea | 222 | ||
PATHOPHYSIOLOGIC CLASSIFICATION OF CENTRAL SLEEP APNEA | 222 | ||
CENTRAL APNEA RISK FACTORS | 223 | ||
MECHANISMS OF BREATHING INSTABILITY IN HEART FAILURE | 224 | ||
SUMMARY | 225 | ||
REFERENCES | 225 | ||
Sleep-Disordered Breathing and Arrhythmia in Heart Failure Patients | 229 | ||
Key points | 229 | ||
INTRODUCTION | 229 | ||
HEART FAILURE AND ARRHYTHMIA | 230 | ||
LINK BETWEEN SLEEP-DISORDERED BREATHING AND CARDIAC ARRHYTHMIA IN HEART FAILURE | 230 | ||
INTERPLAY OF SDB AND CARDIAC ARRHYTHMIA: PATHOPHYSIOLOGY AND AUTONOMIC TONE | 231 | ||
SLEEP-DISORDERED BREATHING PATHOPHYSIOLOGY AND SYSTEMIC CARDIOVASCULAR EFFECTS | 231 | ||
SLEEP-DISORDERED BREATHING AND ATRIAL FIBRILLATION | 232 | ||
SLEEP-DISORDERED BREATHING AND ATRIAL FIBRILLATION: PATHOPHYSIOLOGY | 232 | ||
SLEEP-DISORDERED BREATHING AND ATRIAL FIBRILLATION: TREATMENT OF ATRIAL FIBRILLATION | 233 | ||
SLEEP-DISORDERED BREATHING AND ATRIAL FIBRILLATION: TREATMENT OF SLEEP-DISORDERED BREATHING | 233 | ||
SLEEP-DISORDERED BREATHING AND SUDDEN CARDIAC DEATH | 234 | ||
SLEEP-DISORDERED BREATHING AND VENTRICULAR ARRHYTHMIA | 234 | ||
SLEEP-DISORDERED BREATHING AND CONDUCTION DISTURBANCES | 235 | ||
SLEEP-DISORDERED BREATHING AND ARRHYTHMIA DAYTIME DISTRIBUTION | 235 | ||
IMPROVING HEART FAILURE AND ARRHYTHMIA BURDEN OUTCOME WITH SLEEP-DISORDERED BREATHING TREATMENT? WHAT IS THE EVIDENCE? | 235 | ||
IS HFPEF DIFFERENT WITH REGARD TO SDB? | 236 | ||
SUMMARY AND OUTLOOK | 236 | ||
REFERENCES | 236 | ||
Device Therapy for Sleep-Disordered Breathing in Patients with Cardiovascular Diseases and Heart Failure | 243 | ||
Key points | 243 | ||
RELEVANCE OF BREATHING DISTURBANCES DURING SLEEP IN CARDIOVASCULAR PATIENTS | 243 | ||
THE HETEROGENEITY OF THE PHENOTYPES OF SLEEP-RELATED BREATHING DISTURBANCES | 244 | ||
OBSTRUCTIVE SLEEP APNEA: FUNCTIONAL AND MECHANICAL ASPECTS | 245 | ||
POSITIVE AIRWAY PRESSURE THERAPY IN OBSTRUCTIVE SLEEP APNEA | 245 | ||
EFFECTS OF CONTINUOUS POSITIVE AIRWAY PRESSURE IN PATIENTS WITH CARDIOVASCULAR DISORDERS AND OBSTRUCTIVE SLEEP APNEA | 246 | ||
PROGNOSTIC IMPACT OF CONTINUOUS POSITIVE AIRWAY PRESSURE IN OBSTRUCTIVE SLEEP APNEA | 246 | ||
CONTINUOUS POSITIVE AIRWAY PRESSURE THERAPY IN HEART FAILURE AND PREDOMINANT OBSTRUCTIVE SLEEP APNEA | 247 | ||
PATHOPHYSIOLOGY OF CENTRAL BREATHING DISTURBANCES DURING SLEEP | 247 | ||
CONTINUOUS POSITIVE AIRWAY PRESSURE IN THE TREATMENT OF CENTRAL BREATHING DISTURBANCES | 247 | ||
ADAPTIVE SERVOVENTILATION | 248 | ||
EVOLUTION OF ADAPTIVE SERVOVENTILATION ALGORITHMS | 248 | ||
ADAPTIVE SERVOVENTILATION IN CHRONIC HEART FAILURE | 248 | ||
CONTROVERSIES ON THE PROGNOSTIC IMPACT OF ADAPTIVE SERVOVENTILATION | 249 | ||
OPEN QUESTIONS ON THE TREATMENT OF SLEEP-DISORDERED BREATHING WITH PREDOMINANT CENTRAL SLEEP APNEA BY ADAPTIVE SERVO VENTIL ... | 250 | ||
SUMMARY | 250 | ||
REFERENCES | 251 | ||
Non–Mask-based Therapies for Central Sleep Apnea in Patients with Heart Failure | 255 | ||
Key points | 255 | ||
INTRODUCTION | 255 | ||
PATHOPHYSIOLOGY | 255 | ||
IDENTIFICATION OF CENTRAL SLEEP APNEA HEART FAILURE PATIENTS | 257 | ||
TREATMENT OPTIONS FOR CENTRAL SLEEP APNEA | 258 | ||
Heart Failure Therapy Optimization | 259 | ||
Positive Airway Pressure Therapies | 259 | ||
Oxygen | 260 | ||
Phrenic Nerve Stimulation | 260 | ||
Additional Therapeutic Concepts | 261 | ||
Medications | 261 | ||
Supplemental carbon dioxide | 262 | ||
Atrial pacing | 262 | ||
SUMMARY | 262 | ||
REFERENCES | 262 |